Developed by Metabolic Pharmaceuticals in Australia, AOD-9604 was engineered to retain the fat-reducing properties of intact growth hormone while eliminating the undesirable effects on glucose metabolism, insulin sensitivity, and tissue growth
Our full peptide collection includes compounds with overlapping and distinct timing requirements
Sure, there were some side effects, but nothing I couldn't handle
Intravenous reduced GSH supplementation reverses endothelial dysfunction in patients with atherosclerosis enhancing NO activity and NO-mediated vasodilation (218)
In addition, a meta-analysis of 1193 patients with baseline SGLT2i use in AMPLITUDE-O and Harmony Outcomes revealed an HR for MACE of 0.78 (95% CI 0.491.24) with SGLT2is and 0.77 (95% CI 0.680.87) without SGLT2is ( P -value for interaction 0.95), and an HR for HHF of 0.34 (95% CI 0.120.96) with SGLT2is and 0.72 (95% CI 0.550.92) without SGLT2is ( P -value for interaction 0.18) [48]
Supplement Facts: Serving Size: 60ml (1/2 shot) / 120ml (full shot) Servings Per Container: 2 / 1 Amount Per Serving: Beta-alanine: 1600mg (1/2 shot) / 3200mg (full shot) Taurine: 1000mg / 2000mg Caffeine: 200mg / 400mg Glucuronolactone: 125mg / 250mg Whey protein isolate: 25mg / 50mg *RI - Reference Intake Ingredients: Water, beta alanine, taurine, caffeine anhydrous, glucuronolactone, acid (citric acid), acidity regulator (E331), flavouring, whey protein isolate (from milk), sweeteners (acesulfame K, sucralose, neotame), preservatives (potassium sorbate, sodium benzoate), maltodextrine